[1]
Simpson, E.L., Fujita, H., Arima, K., Hamilton, J., Lu, Y., Rossi, A.B. and Bansal, A. 2020. Dupilumab Decreases Blood Biomarkers in Adolescents With Moderate-to-Severe Atopic Dermatitis: Data From a Phase 3 Trial (LIBERTY AD ADOL). SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s49. DOI:https://doi.org/10.25251/skin.4.supp.48.